Anti-CD7 and anti-CD19 chimeric antigen receptor T cell therapy |
GC-197 |
Phase 2 Clinical |
Gracell Biotechnologies (Shanghai) Co Ltd |
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma |
Details
|
BEAM-201 |
BEAM-201 |
Phase 2 Clinical |
Beam Therapeutics Inc |
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, T-Cell |
Details
|
Autologous and Donor-derived CD7 CAR-T Therapy(Beijing GoBroad Hospital) |
|
Phase 2 Clinical |
Beijing GoBroad Hospital |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma |
Details
|
CD7-CAR-T Cells Therapy |
CD7-CART01 |
Phase 2 Clinical |
Bambino Gesu Hospital And Research Institute |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma |
Details
|
Humanized CD7 CAR-T cells |
|
Phase 2 Clinical |
The First Affiliated Hospital Of Soochow University |
Lymphoma, T-Cell |
Details
|
WU-CART-007 |
WU-CART-007 |
Phase 2 Clinical |
Wugen Inc |
Lymphoma, T-Cell, Peripheral; Enteropathy-Associated T-Cell Lymphoma; Leukemia-Lymphoma, Adult T-Cell; Lymphoma, Primary Cutaneous Anaplastic Large Cell; Lymphoma, Extranodal NK-T-Cell; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sezary Syndrome; Lymphoma, Large-Cell, Anaplastic; Leukemia, Myeloid, Acute; Lymphoma, T-Cell; Leukemia, Prolymphocytic, T-Cell; Mycosis Fungoides |
Details
|
Anti-CD7 CAR T-cell therapy (Yake Biotechnology) |
|
Phase 2 Clinical |
Shanghai YaKe Biotechnology Co Ltd |
Leukemia; Still's Disease, Adult-Onset; Hematologic Diseases; Dermatomyositis; Neoplasms; Autoimmune Diseases; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Colitis, Ulcerative; Lymphoma; Lymphoma, T-Cell; Crohn Disease; Leukemia, T-Cell |
Details
|
CD7-CAR-T cell therapy (PersonGen Biomedicine) |
|
Phase 2 Clinical |
Persongen Biotherapeutics (Suzhou) Co Ltd, The First Affiliated Hospital Of Zhengzhou University |
Leukemia; Enteropathy-Associated T-Cell Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Lymphoma, Extranodal NK-T-Cell; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Lymphoma, Large-Cell, Anaplastic; Leukemia, Myeloid, Acute; Lymphoma, T-Cell |
Details
|
GC-027 |
GC-027 |
Phase 1 Clinical |
Gracell Biotechnologies (Shanghai) Co Ltd |
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma |
Details
|
MB-107(March Biosciences) |
MB-107(March Biosciences) |
Phase 1 Clinical |
March Biosciences Inc |
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Lymphoma, T-Cell |
Details
|
Universal 4SCAR7U T Cell Therapy (Shenzhen Geno-Immune Medical Institute) |
4SCAR7U T cells |
Phase 1 Clinical |
Shenzhen Geno-Immune Medical Institute |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myeloid, Acute; Lymphoma |
Details
|
RD13-02 |
RD13-02 |
Phase 1 Clinical |
Nanjing Bioheng Biotech Co Ltd, Zhejiang University |
Hematologic Neoplasms; Hematologic Diseases; Neoplasms |
Details
|
Anti-CD7 Chimeric Antigen Receptor T-Cell therapy(Bioceltech Therapeutics) |
BT-007 |
Phase 1 Clinical |
Gracell Biotechnologies (Shanghai) Co Ltd, Bioceltech Therapeutics Ltd |
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma |
Details
|
BE CAR-7 |
BE-CAR-7 |
Phase 1 Clinical |
Great Ormond Street Hospital For Children Nhs Foundation Trust |
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Prolymphocytic, T-Cell |
Details
|
Anti-CD7 CAR-T cell Therapy (Shanghai General Hospital) |
|
Phase 1 Clinical |
Shanghai General Hospital |
Lymphoma, T-Cell, Peripheral; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Lymphoma, Large-Cell, Anaplastic; Leukemia, T-Cell |
Details
|
This CAR-T-7 cells therapy |
This CAR-T-7 cells |
Phase 1 Clinical |
Fundamenta Therapeutics Ltd |
Leukemia, Lymphoid; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Lymphoma, T-Cell |
Details
|
GC-502 |
GC-502 |
Phase 1 Clinical |
Gracell Biotechnologies (Shanghai) Co Ltd |
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Lymphoma, Non-Hodgkin |
Details
|
CD7 CARvac T cell therapy |
|
Phase 1 Clinical |
Icell Gene Therapeutics (Int'L) Ltd |
Hematologic Neoplasms; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Lymphoma |
Details
|
SenL-T7 CAR T Cells (Hebei Senlang Biological) |
Senl-T7; Senl-T-7; SENL-101 |
Phase 1 Clinical |
Hebei Senlang Biological Technology Co Ltd |
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Lymphoma, T-Cell; Leukemia, T-Cell |
Details
|
PA3-17 |
PA3-17; PA-3-17; PA3-17 (autologous) |
Phase 1 Clinical |
Persongen Anke Cell Technology Co Ltd, Persongen Biotherapeutics (Suzhou) Co Ltd |
Hematologic Neoplasms; Lymphoma |
Details
|
CAR7-T Cell Therapy (Beijing Gaobo Biotechnology Co Ltd) |
|
Phase 1 Clinical |
Wuhan Union Hospital |
Lymphoma, T-Cell; Leukemia, T-Cell; Leukemia, Lymphocytic, Chronic, B-Cell |
Details
|
CD7 targeted CAR-γδ T cells therapy(Persongen Bio) |
|
Phase 1 Clinical |
Persongen Biotherapeutics (Suzhou) Co Ltd |
Neoplasms; Leukemia, B-Cell |
Details
|
CD7 CAR-T cell therapy (Hebei Senlang Biotechnology) |
|
Phase 1 Clinical |
Hebei Senlang Biological Technology Co Ltd |
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma |
Details
|
RD13-01 |
RD13-01; CTD-401 |
Clinical |
Zhejiang University, Nanjing Bioheng Biotech Co Ltd |
Hematologic Neoplasms |
Details
|
Anti-CD7 CAR-T Cell Therapy (iCell Gene Therapeutics) |
|
|
iCell Gene Therapeutics LLC |
|
Details
|
Anti-CD7 and anti-CD19 chimeric antigen receptor T cell therapy |
GC-197 |
Phase 2 Clinical |
Gracell Biotechnologies (Shanghai) Co Ltd |
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma |
Details
|
BEAM-201 |
BEAM-201 |
Phase 2 Clinical |
Beam Therapeutics Inc |
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, T-Cell |
Details
|
Autologous and Donor-derived CD7 CAR-T Therapy(Beijing GoBroad Hospital) |
|
Phase 2 Clinical |
Beijing GoBroad Hospital |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma |
Details
|
CD7-CAR-T Cells Therapy |
CD7-CART01 |
Phase 2 Clinical |
Bambino Gesu Hospital And Research Institute |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma |
Details
|
Humanized CD7 CAR-T cells |
|
Phase 2 Clinical |
The First Affiliated Hospital Of Soochow University |
Lymphoma, T-Cell |
Details
|
WU-CART-007 |
WU-CART-007 |
Phase 2 Clinical |
Wugen Inc |
Lymphoma, T-Cell, Peripheral; Enteropathy-Associated T-Cell Lymphoma; Leukemia-Lymphoma, Adult T-Cell; Lymphoma, Primary Cutaneous Anaplastic Large Cell; Lymphoma, Extranodal NK-T-Cell; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sezary Syndrome; Lymphoma, Large-Cell, Anaplastic; Leukemia, Myeloid, Acute; Lymphoma, T-Cell; Leukemia, Prolymphocytic, T-Cell; Mycosis Fungoides |
Details
|
Anti-CD7 CAR T-cell therapy (Yake Biotechnology) |
|
Phase 2 Clinical |
Shanghai YaKe Biotechnology Co Ltd |
Leukemia; Still's Disease, Adult-Onset; Hematologic Diseases; Dermatomyositis; Neoplasms; Autoimmune Diseases; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Colitis, Ulcerative; Lymphoma; Lymphoma, T-Cell; Crohn Disease; Leukemia, T-Cell |
Details
|
CD7-CAR-T cell therapy (PersonGen Biomedicine) |
|
Phase 2 Clinical |
Persongen Biotherapeutics (Suzhou) Co Ltd, The First Affiliated Hospital Of Zhengzhou University |
Leukemia; Enteropathy-Associated T-Cell Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Lymphoma, Extranodal NK-T-Cell; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Lymphoma, Large-Cell, Anaplastic; Leukemia, Myeloid, Acute; Lymphoma, T-Cell |
Details
|
GC-027 |
GC-027 |
Phase 1 Clinical |
Gracell Biotechnologies (Shanghai) Co Ltd |
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma |
Details
|
MB-107(March Biosciences) |
MB-107(March Biosciences) |
Phase 1 Clinical |
March Biosciences Inc |
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Lymphoma, T-Cell |
Details
|
Universal 4SCAR7U T Cell Therapy (Shenzhen Geno-Immune Medical Institute) |
4SCAR7U T cells |
Phase 1 Clinical |
Shenzhen Geno-Immune Medical Institute |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myeloid, Acute; Lymphoma |
Details
|
RD13-02 |
RD13-02 |
Phase 1 Clinical |
Nanjing Bioheng Biotech Co Ltd, Zhejiang University |
Hematologic Neoplasms; Hematologic Diseases; Neoplasms |
Details
|
Anti-CD7 Chimeric Antigen Receptor T-Cell therapy(Bioceltech Therapeutics) |
BT-007 |
Phase 1 Clinical |
Gracell Biotechnologies (Shanghai) Co Ltd, Bioceltech Therapeutics Ltd |
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma |
Details
|
BE CAR-7 |
BE-CAR-7 |
Phase 1 Clinical |
Great Ormond Street Hospital For Children Nhs Foundation Trust |
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Prolymphocytic, T-Cell |
Details
|
Anti-CD7 CAR-T cell Therapy (Shanghai General Hospital) |
|
Phase 1 Clinical |
Shanghai General Hospital |
Lymphoma, T-Cell, Peripheral; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Lymphoma, Large-Cell, Anaplastic; Leukemia, T-Cell |
Details
|
This CAR-T-7 cells therapy |
This CAR-T-7 cells |
Phase 1 Clinical |
Fundamenta Therapeutics Ltd |
Leukemia, Lymphoid; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Lymphoma, T-Cell |
Details
|
GC-502 |
GC-502 |
Phase 1 Clinical |
Gracell Biotechnologies (Shanghai) Co Ltd |
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Lymphoma, Non-Hodgkin |
Details
|
CD7 CARvac T cell therapy |
|
Phase 1 Clinical |
Icell Gene Therapeutics (Int'L) Ltd |
Hematologic Neoplasms; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Lymphoma |
Details
|
SenL-T7 CAR T Cells (Hebei Senlang Biological) |
Senl-T7; Senl-T-7; SENL-101 |
Phase 1 Clinical |
Hebei Senlang Biological Technology Co Ltd |
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Lymphoma, T-Cell; Leukemia, T-Cell |
Details
|
PA3-17 |
PA3-17; PA-3-17; PA3-17 (autologous) |
Phase 1 Clinical |
Persongen Anke Cell Technology Co Ltd, Persongen Biotherapeutics (Suzhou) Co Ltd |
Hematologic Neoplasms; Lymphoma |
Details
|
CAR7-T Cell Therapy (Beijing Gaobo Biotechnology Co Ltd) |
|
Phase 1 Clinical |
Wuhan Union Hospital |
Lymphoma, T-Cell; Leukemia, T-Cell; Leukemia, Lymphocytic, Chronic, B-Cell |
Details
|
CD7 targeted CAR-γδ T cells therapy(Persongen Bio) |
|
Phase 1 Clinical |
Persongen Biotherapeutics (Suzhou) Co Ltd |
Neoplasms; Leukemia, B-Cell |
Details
|
CD7 CAR-T cell therapy (Hebei Senlang Biotechnology) |
|
Phase 1 Clinical |
Hebei Senlang Biological Technology Co Ltd |
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma |
Details
|
RD13-01 |
RD13-01; CTD-401 |
Clinical |
Zhejiang University, Nanjing Bioheng Biotech Co Ltd |
Hematologic Neoplasms |
Details
|
Anti-CD7 CAR-T Cell Therapy (iCell Gene Therapeutics) |
|
|
iCell Gene Therapeutics LLC |
|
Details
|